Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-06-03
2010-02-16
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S339000, C514S372000
Reexamination Certificate
active
07662834
ABSTRACT:
This invention relates to treating cancer or an angiogenesis-related disease using a compound of formula 1:wherein R1, R2, R3, R4, and n are defined herein.
REFERENCES:
patent: 2825734 (1958-03-01), Speeter
patent: 3351630 (1967-11-01), Shen
patent: 5192770 (1993-03-01), Clark et al.
patent: 6008231 (1999-12-01), Lebaut et al.
patent: 6114355 (2000-09-01), D'Amato
patent: 6232327 (2001-05-01), Nickel et al.
patent: 6251923 (2001-06-01), Hofgen et al.
patent: 6469006 (2002-10-01), Blair et al.
patent: 6613794 (2003-09-01), Hofgen et al.
patent: 198 18 964 (1999-11-01), None
patent: 0 657 110 (1995-10-01), None
patent: 1028812 (1966-05-01), None
patent: 57006878 (1982-01-01), None
patent: 6502481 (1965-02-01), None
patent: WO 99/51224 (1999-10-01), None
patent: WO 02/08225 (2002-01-01), None
patent: WO 03/022280 (2003-03-01), None
Dorwald F. A. Side Reactions in Organic Synthesis, 2005, Wiley: VCH, Weinheim p. IX of Preface.
Draetta, G et. al., Annual Rports in medicinal Chemistry, vol. 31, 1996, p. 241-246.
Brown, et. al., Oncol Res. 1997, 9(5), p. 213-215.
Weinstein et. al., Science, 1997, 275(5298), p. 343-349.
Hamburger et. al., JNCL, 66 (6) 1981, p. 981-986.
Cecil Textbook of Medicine, 21st Edition (2000), Goldman & Bennett (Editors), W.B. Saunders Company (Publisher), Chapter 198, pp. 1060-1074.
Internal Medicine, 4th Edition, Editor-in-Chief Jay Stein, Chapters 71-72, pp. 699-715.
Patterson, A. M. et al., “The Ring Index 2ndEd.”, American Chemical Society, Columbus, OH 1960, entry #2527, p. 326.
Draetta, G. et al., Annual Reports in Medicinal Chemistry, vol. 31, 1996, p. 241-246.
Brown, et al., Oncol. Res. 1997 9(5), p. 213-215.
Weinstein et al., Science, 1997, 275(5298), p. 343-349.
Hamburger et al., JNCL, 66(6) 1981, p. 981-986.
In reRainer, 146 USPQ 218 (1965).
In reColianni, 195 USPQ 150,Ex parte Formal, 230 USPQ 546.
In reFisher, 427 F.2d 833, 839; 166 USPQ 18, 24 (CCPA 1970).
In reWright, 999 F.2d 1557, 1562; 27 USP@2d 1510, 1513 (Fed. Cir. 1993).
Chen Chiung-Tong
Chen Shu-Jen
Hsu Ming-Chu
Hwang Der-Ren
Li Wen-Tai
Murray Jeffrey H
National Health Research Institutes
Occhiuti Rohlicek & Tsao LLP
Wilson James O
LandOfFree
Methods of 1H-indol-3-yl-2-oxoacetamide compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of 1H-indol-3-yl-2-oxoacetamide compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of 1H-indol-3-yl-2-oxoacetamide compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4231619